Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16854634 | 1.00 | TSHR (0.61) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL18290484 | 1.00 | TSHR (0.61) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL1320955 | 0.86 | TSHR (0.61) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL19862455 | 0.84 | TSHR (0.59) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL22385137 | 0.82 | TSHR (0.44) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL7640985 | 0.82 | TSHR (0.42) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL85888 | 0.82 | TSHR (0.57) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL16517868 | 0.82 | TSHR (0.57) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL1463851 | 0.82 | TSHR (0.57) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL16808766 | 0.82 | TSHR (0.57) | TSHRMAPK1ALDH1A1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111793276-B | Modified polypropylene material with high laser welding strength and preparation method thereof | 万华化学(四川)有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-116376489-A | Dual-curing fluorine-containing epoxy adhesive | 上海本诺电子材料有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-113529183-B | Gel preparation process of heating fiber | 吉祥三宝高科纺织有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114686157-A | Three-dimensional reticular polymer for adhesive and preparation method thereof | 江苏环峰电工材料有限公司广州分公司 | 2022-07-01 | — | — | CN | claimed |
| CN-113529183-A | Gel preparation process of heating fiber | 吉祥三宝高科纺织有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-111793276-A | High-laser-welding-strength modified polypropylene material and preparation method thereof | 万华化学（宁波）有限公司 | 2020-10-20 | — | — | CN | claimed |
| US-20260098032-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | PMV PHARMACEUTICALS INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260055011-A1 | AMINE-BASED SOLVENTS FOR TEMPERATURE SWING SOLVENT EXTRACTION | UNIV ALABAMA (US) | 2026-02-26 | — | — | US | disclosed |
| EP-4644387-A2 | METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION | PMV Pharmaceuticals, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12428406-B2 | Methods and compounds for restoring mutant p53 function | PMV PHARMACEUTICALS, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| CN-111793276-B | Modified polypropylene material with high laser welding strength and preparation method thereof | 万华化学(四川)有限公司 | 2023-12-19 | — | — | CN | disclosed |
| US-11814373-B2 | Methods and compounds for restoring mutant p53 function | PMV PHARMACEUTICALS, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814373-B2 | Methods and compounds for restoring mutant p53 function | PMV PHARMACEUTICALS, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| EP-0147758-A2 | Polyesters modified with polymers of alkylene oxids | The B.F. GOODRICH Company (US) | 1985-07-10 | — | — | EP | disclosed |
| US-4511742-A | Extraction of oligomers from polymers of epihalohydrin | THE B. F. GOODRICH COMPANY (US) | 1985-04-16 | — | — | US | disclosed |
| US-4508916-A | Curable substituted urethane acrylates | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-04-02 | — | — | US | disclosed |
| US-4490560-A | USING COLUMN OF AMORPHOUS SILICA | THE B. F. GOODRICH COMPANY (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0107080-A1 | Decolorizing polymers of epihalohydrin | The B.F. GOODRICH Company (US) | 1984-05-02 | — | — | EP | disclosed |
| EP-0104462-A1 | Extraction of oligomers from polymers of epihalohydrin | The B.F. GOODRICH Company (US) | 1984-04-04 | — | — | EP | disclosed |
| EP-0103296-A2 | Epihalohydrin polymers | The B.F. GOODRICH Company (US) | 1984-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055011-A1 | AMINE-BASED SOLVENTS FOR TEMPERATURE SWING SOLVENT EXTRACTION | SLC6A12, SLC6A6, SLC6A9 | TSHR 328/4885MAPK1 581/4885ALDH1A1 2571/4885 |
| US-12428406-B2 | Methods and compounds for restoring mutant p53 function | TP53, TP53BP1, KRAS | TSHR 3846/4885MAPK1 2448/4885ALDH1A1 1538/4885 |
| US-11814373-B2 | Methods and compounds for restoring mutant p53 function | TP53, TP53BP1, KRAS | TSHR 3846/4885MAPK1 2448/4885ALDH1A1 1538/4885 |
| US-20260098032-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | TP53, TP53BP1, MDM2 | TSHR 2535/4885MAPK1 646/4885ALDH1A1 4027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.